Roche Foundation Medicine are collaborating to pioneer progress in precision medicine for cancer patients around the world
As part of our long-standing commitment to pioneering progress in precision medicine, molecular insights leader Foundation Medicine has become a member of the Roche Group. Thanks to Roche’s expertise and commitment in oncology and Foundation Medicine’s leading technology, validation and experience in cancer profiling, together we are:1
- Increasing understanding of tumours and providing insights on clinical trials to consider, to enable smarter, more efficient research and development
- Improving patient care by providing genomic insights with associated targeted therapies, immunotherapies and relevant clinical trials
Date of item: January 2022. M-IE-00000628
References
- Roche Media Release, 2018. Available at: https://www.roche.com/media/releases/med-cor-2018-06-19.htm (Accessed August 2021).